[stock_market_widget type=”leaderboard” template=”color-background” color=”olive” assets=”CRSP” api=”yf”]
CRISPR Therapeutics AG
Description: CRISPR Therapeutics AG, develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), a revolutionary gene editing technology that allows for precise directed changes to genomic DNA. It has a portfolio of therapeutic programs in a range of disease areas, including hemoglobinopathies, immuno-oncology, regenerative medicine, and rare diseases. The company has a strategic collaboration and license agreement with Vertex Pharmaceuticals Inc.
Industry: Biotechnology
Founded Year : 2013
Headquarter : Zug, Switzerland
Website: http://www.crisprtx.com
Phone: 41 41 561 3277
[stock_market_widget type=”leaderboard” template=”color-background” color=”blue” assets=”ALLO” api=”yf”]
Allogene Therapeutics, Inc.
Description: Allogene Therapeutics, is a clinical stage immuno-oncology company, developing genetically engineered allogeneic T cell therapies for the treatment of cancer. The company has a research collaboration agreement with Stanford University to investigate a novel nucleic acid delivery system.
Industry: Biotechnology
Founded Year : 2017
Headquarter : South San Francisco, CA, U.S.A
Website: http://www.allogene.com
Phone: 650-457-2700
[stock_market_widget type=”leaderboard” template=”color-background” color=”blue” assets=”BHVN” api=”yf”]
Biohaven Pharmaceutical Holding Company Ltd.
Description: Biohaven Pharmaceutical Holding Company Ltd., a clinical-stage biopharmaceutical company, develops late-stage products candidates targeting neurological diseases in the United States.
Industry: Biotechnology
Founded Year : 2010
Headquarter : New Haven, CT, U.S.A
Website: http://www.biohavenpharma.com
Phone: 203-404-0410
[stock_market_widget type=”leaderboard” template=”color-background” color=”blue” assets=”MYOK” api=”yf”]
MyoKardia, Inc.
Description: MyoKardia, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. The company has a collaboration with 23andMe, Inc., a consumer genetics and research company.
Industry: Biotechnology
Founded Year : 2012
Headquarter : South San Francisco, CA, U.S.A
Website: http://www.myokardia.com
Phone: 650-741-0900
[stock_market_widget type=”leaderboard” template=”color-background” color=”red” assets=”ZLAB” api=”yf”]
Zai Lab Ltd
Description: Zai Lab Limited, a biopharmaceutical company, engages in discovering or licensing, developing, and commercializing proprietary therapeutics that address medical needs in the fields of oncology, infectious, and autoimmune diseases in China and internationally. Zai Lab has license and collaboration agreements with the TESARO; Paratek Bermuda, Ltd.; Five Prime Therapeutics, Inc.; Bristol-Myers Squibb Company; Entasis Therapeutics Holdings, Inc.; Sanofi; MacroGenics Inc.; and NovoCure Limited.
Industry: Biotechnology
Founded Year : 2013
Headquarter : Shanghai, China
Website: http://www.zailaboratory.com
Phone: 86 21 6163 2588
No comment yet, add your voice below!